A closer look at the technologies used by Bard Pharmaceuticals
Bard Pharmaceuticals
Manufacturing · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Science Park Unit 191, Cambridge, Cambri...Phone Number
+44 1223424444Revenue
$29.9 MillionIndustry
About Bard Pharmaceuticals
Bard Pharmaceuticals was founded in 1966 serving as the Production and Supply Chain and Quality division of the Napp Pharmaceutical Group. In the 1970s, the company began production of the Continus® system, a prolonged release technology, which has been combined with a variety of existing, effective medicines to bring additional benefits to patients. This was one of the most important founding achievements of the company's business and the company still produce medicines using this system onsite today. Over the years the company has continued to develop alternative prolonged release formulations and expanded the company's portfolio of medicines in a variety of therapy areas, including pain and respiratory medicine. 1983 saw the company relocate from three sites; Aberdeen, Watford and West Drayton to the company's iconic main building on the Cambridge Science Park, affectionately known as the toast rack. The company's award winning building was designed by Canadian architect, Arthur EriRead more
SIC Code 28,283NAICS Code 32,325Show moreCompare Similar Companies to Bard Pharmaceuticals
Compare insights from companies similar to Bard Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bard Pharmaceuticals
$29.9M
201-500
Private
-
1966
N/A
Bard Pharmaceuticals Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Bard Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Bard Pharmaceuticals was founded in 1966 serving as the Production and Supply Chain and Quality division of the Napp Pharmaceutical Group. In the 1970s, the company began production of the Continus® system, a prolonged release technology, which has been combined with a variety of existing, effective medicines to bring additional benefits to patient... Read More